Medicare

BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

CardiAMP cell therapy-treated patients had 37% relative risk reduction in heart death equivalent (death, heart transplant, left ventricular assist device...

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional...

Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update

Full year 2023 total revenues of $464.4 million, compared to $250.3 million in 2022 Full year 2023 CAPLYTA net product...

CloudMD and Bristol Health Medical Group Announce the Launch of the Breakthrough Deviceless Remote Patient Monitoring Program

Bristol Health Embraces Innovation by Launching its Inaugural Remote Patient Monitoring Program Utilizing CloudMD's HealthyLYF PlatformVancouver, British Columbia--(Newsfile Corp. -...

Healthcare Data Interoperability – Exploring Growth Opportunities up to 2028: Industry Convergence Leads to New Growth Opportunities

DUBLIN, Feb. 15, 2024 /PRNewswire/ -- The "Global Healthcare Data Interoperability Growth Opportunities Forecast to 2028" report has been added to ResearchAndMarkets.com's offering....

error: Content is protected !!